Novel Soluble Amylin Formulations for Co-injection with Insulin
Amylin variants which are much more soluble than the wild type peptide, designed to be co-formulated with insulin to treat diabetes. Background: Administration of Islet Amyloid Polypeptide IAPP with Insulin (as a separate injection) helps to normalize fluctuating glucose levels to a greater degree than is possible with insulin alone. Unfortunately,...
Published: 2/28/2024
|
Inventor(s): Daniel Raleigh, Andisheh Abedini
Keywords(s): Technologies
Category(s): Campus > Stony Brook University, Technology Classifications > Therapeutics
|